34S: A New Opportunity for the Efficient Synthesis of Stable Isotope Labeled Compounds

被引:5
作者
Ren, Sumei [1 ]
Fier, Patrick S. [1 ]
Ren, Hong [1 ]
Hoover, Andrew J. [1 ]
Hesk, David [1 ]
Marques, Rosemary [1 ]
Mergelsberg, Ingrid [1 ]
机构
[1] Merck Sharp & Dohme Corp, MRL, Dept Proc Res & Dev, Rahway, NJ 07065 USA
关键词
absolute bioavailability; isotopic labeling; oligonucleotides; solid-phase synthesis; sulfur-34; ABSOLUTE BIOAVAILABILITY; SOLID-PHASE; OLIGONUCLEOTIDES; RNA; PHOSPHOROTHIOATES; SULFUR; C-13;
D O I
10.1002/chem.201801494
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The synthesis of stable isotope labeled (SIL) complex drug molecules with >= 3 mass unit increase from the parent compound is essential for drug discovery and development. Typical approaches that rely on H-2, C-13, and N-15 isotopes can be very challenging or even intractable, and can delay the drug development process. This work introduces a new concept for the synthesis of labeled compounds that relies on the use of S-34. The synthetic utility of S-34 was demonstrated with the efficient synthesis of [S-34]phosphorothioates [S-34(2)]-PS-ODNs-TTT and [C-13, N-15, S-34]-ceftolozane. In addition, a procedure for the direct oxidation of phosphites to [S-34]phosphorothioates using elemental S-34 without isotope dilution was developed.
引用
收藏
页码:7133 / 7136
页数:4
相关论文
共 25 条
[11]   Synthesis of isotopically labelled compounds at Schering-Plough, an historical perspective [J].
Hesk, D. ;
McNamara, P. .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2007, 50 (9-10) :875-887
[12]   Patent Review of Manufacturing Routes to Fifth-Generation Cephalosporin Drugs. Part 1, Ceftolozane [J].
Hughes, David L. .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2017, 21 (03) :430-443
[13]   Data-Mining for Sulfur and Fluorine: An Evaluation of Pharmaceuticals To Reveal Opportunities for Drug Design and Discovery [J].
Ilardi, Elizabeth A. ;
Vitaku, Edon ;
Njardarson, Jon T. .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (07) :2832-2842
[14]   The use of stable isotope-labeled drug as microtracers with conventional LC-MS/MS to support human absolute bioavailability studies: are we there yet? [J].
Ma, Shuguang ;
Chowdhury, Swapan K. .
BIOANALYSIS, 2016, 8 (08) :731-733
[15]   The first example of sequence-specific non-uniformly 13C5 labelled RNA:: Synthesis of the 29mer HIV-1 TAR RNA with 13C relaxation window [J].
Milecki, J ;
Zamaratski, E ;
Maltseva, TV ;
Földesi, A ;
Adamiak, RW ;
Chattopadhyaya, J .
TETRAHEDRON, 1999, 55 (21) :6603-6622
[16]  
Moshos K. A., 2016, Patent, Patent No. [WO 2016100897, A1 20160623, 2016100897]
[17]   The application of sulphur isotope analyses in archaeological research: A review [J].
Nehlich, Olaf .
EARTH-SCIENCE REVIEWS, 2015, 142 :1-17
[18]  
Pedras MSC, 2008, ORG BIOMOL CHEM, V6, P51, DOI [10.1039/b714743k, 10.1039/B714743K]
[19]   Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activity [J].
Qian, L ;
Xu, Y ;
Hasegawa, Y ;
Aoki, J ;
Mills, GB ;
Prestwich, GD .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (26) :5575-5578
[20]   CHEMICAL SYNTHESIS OF C-13-LABELED MONOMERS FOR THE SOLID-PHASE AND TEMPLATE CONTROLLED ENZYMATIC-SYNTHESIS OF DNA AND RNA OLIGOMERS [J].
QUANT, S ;
WECHSELBERGER, RW ;
WOLTER, MA ;
WORNER, KH ;
SCHELL, P ;
ENGELS, JW ;
GRIESINGER, C ;
SCHWALBE, H .
TETRAHEDRON LETTERS, 1994, 35 (36) :6649-6652